Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Intended setting: Laboratory research use
It is manufactured by Novo Nordisk and is available under two primary brand names: Ozempic FDA-approved for type 2 diabetes management Wegovy FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity Semaglutide is administered as a once-weekly subcutaneous injection, making it one of the most convenient weight loss medications in terms of dosing frequency
The FDA explicitly warns against using illegally marketed or compounded drugs without proper medical oversight, emphasizing the critical safety advantage of regulated pharmaceuticals over unregulated supplements like berberine
Retatrutide is an investigational triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, targeting appetite, insulin sensitivity, and energy expenditure a broader mechanism than currently licensed weight management medicines
J Am Geriatr Soc 65: 1462-1469
US$ 29.26
US$ 23.81
US$ 24.43
US$ 21.63
US$ 25.20
US$ 28.03
US$ 28.60
